---
title: "300347.SZ (300347.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300347.SZ/news.md"
symbol: "300347.SZ"
name: "300347.SZ"
parent: "https://longbridge.com/en/quote/300347.SZ.md"
datetime: "2026-05-20T02:20:29.814Z"
locales:
  - [en](https://longbridge.com/en/quote/300347.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300347.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300347.SZ/news.md)
---

# 300347.SZ (300347.SZ) — Related News

### [12 years of non-disclosure, a notice of case filing: Tigermed's dignity shattered](https://longbridge.com/en/news/286858530.md)
*2026-05-19T05:25:57.000Z*
> The actual controllers of Hangzhou Tigermed Consulting Co., Ltd. are under investigation by the China Securities Regulat

### [TIGERMED fell 3% in half a day, hitting a nearly one-year low, and was downgraded by JP Morgan with a target price of 39 yuan](https://longbridge.com/en/news/286852547.md)
*2026-05-19T04:06:56.000Z*
> Tigermed closed down 3.19% today at CNY 33.42, hitting a nearly one-year low. JP Morgan lowered its target price for its

### [The actual controller has been put under investigation, and the 1 billion repurchase "market protection" has failed: Tigermed's stock price has fallen over 9% in three days](https://longbridge.com/en/news/286668903.md)
*2026-05-17T09:53:11.000Z*
> Tigermed announced a share repurchase plan of up to 1 billion yuan to "support the stock" due to the investigation of it

### [Xingzheng Global Fund increased its holdings in Tigermed by 719,300 shares at an approximate price of HKD 35.93 per share](https://longbridge.com/en/news/286566871.md)
*2026-05-15T12:38:03.000Z*
> According to the latest information from the Hong Kong Stock Exchange, on May 14, Xingzheng Global Fund increased its ho

### [Tigermed Executive Director Cao Xiaochun released 20 million shares from pledge, reducing pledged shares to 18.5 million shares](https://longbridge.com/en/news/286486456.md)
*2026-05-15T00:42:00.000Z*
> According to a report from Economic Information Daily on the 15th, Tigermed (Shenzhen: 300347) announced that shareholde

### [Innovative drug "water seller" fails in information disclosure, 10 years of reduction leads to CSRC investigation](https://longbridge.com/en/news/286429492.md)
*2026-05-14T13:47:41.000Z*
> TIGERMED is under investigation by the China Securities Regulatory Commission for information disclosure violations, and

### [How can Tigermed escape the chain reaction after the actual controller's disclosure violation is under investigation?](https://longbridge.com/en/news/286388261.md)
*2026-05-14T08:56:04.000Z*
> The actual controller of Tigermed is under investigation by the China Securities Regulatory Commission for suspected vio

### [Tigermed had a late-night "explosion": the actual controller is under investigation, 75% of shares are under pressure, and the performance "inflation" can no longer be hidden](https://longbridge.com/en/news/286377688.md)
*2026-05-14T07:28:09.000Z*
> Tigermed is under investigation by the China Securities Regulatory Commission for suspected violations of information di

### [Is this the boss taking the blame for the secretary of the board?](https://longbridge.com/en/news/286370105.md)
*2026-05-14T05:45:20.000Z*
> The two actual controllers of Tigermed are under investigation for failing to timely announce changes in shareholding. T